Oslo, Norway

Jan-Egil Melvik

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fmc Biopolymer as. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan-Egil Melvik. Retrieved from https://idiyas.com/inventor/jan-egil-melvik-3gtfjib7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan-Egil Melvik: Innovator in Self-Gelling Alginate Systems

Introduction

Jan-Egil Melvik is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of biopolymers, particularly through his innovative work on self-gelling alginate systems. His research focuses on developing kits and compositions that facilitate the production of alginate gels, which have various applications in medical and biotechnological fields.

Latest Patents

Jan-Egil Melvik holds a patent for "Self-gelling alginate systems and uses thereof." This patent describes kits and compositions that include soluble alginate and insoluble alginate/gelling ion particles. The methods outlined in the patent involve forming a dispersion of these particles in a solution containing soluble alginate, which can then be dispensed to create an alginate gel matrix. Notably, the alginate gel produced can have a thickness greater than 5 mm and features a homogeneous alginate matrix network. The patent also discusses implantable devices coated with this alginate gel and methods to enhance the viability of pancreatic islets and other cellular aggregates during storage and transport.

Career Highlights

Jan-Egil Melvik is associated with Fmc Biopolymer AS, where he continues to advance his research in biopolymer applications. His work has garnered attention for its potential to improve medical treatments and biotechnological processes.

Collaborations

Throughout his career, Jan-Egil has collaborated with notable colleagues, including Michael Dornish and Edvar Onsoyen. These collaborations have contributed to the development and refinement of his innovative alginate systems.

Conclusion

Jan-Egil Melvik's contributions to the field of self-gelling alginate systems highlight his role as a key innovator in biopolymer research. His patented technologies have the potential to impact various medical applications significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…